| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |